Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Visudyne verteporfin: Phase II data; marketed for certain other forms of wet AMD

In the Visudyne in Minimally Classic (VIM) international Phase II study in

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE